As a professor of chemistry, biochemistry and molecular biology at the University of California, Berkeley, Doudna leads the Doudna Lab, which employs undergraduate and graduate students to study the ...
platform for the delivery of CRISPR/Cas9 to the liver. The first two in vivo programs utilizing this proprietary platform, CTX310™ and CTX320™, are directed towards validated therapeutic ...
A patient with sickle cell disease died while participating in a clinical trial of a CRISPR-based treatment from Beam Therapeutics, threatening to overshadow early signals of effective gene editing.
The team used the CRISPR/Cas9 gene-editing technique to modify the dsx gene in select bees ... For example, roboticists often look to nature for insights into building more efficient, cooperative ...
Jennifer Doudna, the co-developer of CRISPR, says there’s a “coming revolution” in climate-adapted crops and animals. Jennifer Doudna, one of the inventors of the breakthrough gene-editing ...